×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NUVB – nuvation bio inc. class a (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NUVB
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/2
08:00 am
nuvb
Nuvation Bio to Present at the Jones Healthcare and Technology Innovation Conference
Low
Report
Nuvation Bio to Present at the Jones Healthcare and Technology Innovation Conference
3/27
08:17 pm
nuvb
Nuvation Bio Inc. (NYSE: NUVB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
Medium
Report
Nuvation Bio Inc. (NYSE: NUVB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
3/25
04:45 pm
nuvb
Nuvation Bio to Present New Nonclinical Data for Taletrectinib at the American Association for Cancer Research Annual Meeting 2025
Medium
Report
Nuvation Bio to Present New Nonclinical Data for Taletrectinib at the American Association for Cancer Research Annual Meeting 2025
3/25
08:34 am
nuvb
Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Crizotinib During Mini Oral Presentation at the European Lung Cancer Congress 2025 [Yahoo! Finance]
Low
Report
Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Crizotinib During Mini Oral Presentation at the European Lung Cancer Congress 2025 [Yahoo! Finance]
3/25
08:00 am
nuvb
Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Crizotinib During Mini Oral Presentation at the European Lung Cancer Congress 2025
Neutral
Report
Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Crizotinib During Mini Oral Presentation at the European Lung Cancer Congress 2025
3/14
06:13 am
nuvb
Nuvation Bio Inc. (NYSE: NUVB) was upgraded by analysts at Jones Trading to a "strong-buy" rating.
Medium
Report
Nuvation Bio Inc. (NYSE: NUVB) was upgraded by analysts at Jones Trading to a "strong-buy" rating.
3/12
08:57 am
nuvb
Nuvation Bio Inc. (NYSE: NUVB) is now covered by analysts at Jones Trading. They set a "buy" rating and a $10.00 price target on the stock.
Medium
Report
Nuvation Bio Inc. (NYSE: NUVB) is now covered by analysts at Jones Trading. They set a "buy" rating and a $10.00 price target on the stock.
3/10
08:03 am
nuvb
Nuvation Bio Inc. (NYSE: NUVB) had its price target lowered by analysts at HC Wainwright from $11.00 to $10.00. They now have a "buy" rating on the stock.
Medium
Report
Nuvation Bio Inc. (NYSE: NUVB) had its price target lowered by analysts at HC Wainwright from $11.00 to $10.00. They now have a "buy" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/3
04:05 pm
nuvb
Form 4 Nuvation Bio Inc. For: Apr 01 Filed by: Mashal Robert
Low
Report
Form 4 Nuvation Bio Inc. For: Apr 01 Filed by: Mashal Robert
3/25
09:05 am
nuvb
Form 8-K Nuvation Bio Inc. For: Mar 21
Low
Report
Form 8-K Nuvation Bio Inc. For: Mar 21
3/6
05:14 pm
nuvb
Form 10-K Nuvation Bio Inc. For: Dec 31
Medium
Report
Form 10-K Nuvation Bio Inc. For: Dec 31
3/6
05:13 pm
nuvb
Form 8-K Nuvation Bio Inc. For: Mar 06
Medium
Report
Form 8-K Nuvation Bio Inc. For: Mar 06
3/5
04:04 pm
nuvb
Form 8-K Nuvation Bio Inc. For: Mar 03
Low
Report
Form 8-K Nuvation Bio Inc. For: Mar 03
3/4
06:37 pm
nuvb
Form 4 Nuvation Bio Inc. For: Feb 28 Filed by: Sjogren Colleen
Low
Report
Form 4 Nuvation Bio Inc. For: Feb 28 Filed by: Sjogren Colleen
3/4
06:37 pm
nuvb
Form 4 Nuvation Bio Inc. For: Feb 28 Filed by: Wentworth Kerry
Low
Report
Form 4 Nuvation Bio Inc. For: Feb 28 Filed by: Wentworth Kerry
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: